Quest Pharmatech Inc
XTSX:QPT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Q
|
Quest Pharmatech Inc
XTSX:QPT
|
CA |
Quest Pharmatech Inc
Quest PharmaTech, Inc. is a biotechnology company, which develops and commercializes antibody based immunotherapeutic products for cancer. The company is headquartered in Edmonton, Alberta. The firm is focused on development and commercialization of immunotherapies for cancer. Its technology platform includes a portfolio of tumor antigen specific monoclonal immunoglobulins targeting CA-125, MUC1, PSA and Her2/neu. The firm is also developing products utilizing transdermal delivery technologies with a focus on dermatology and wound healing applications. The firm is exploring the therapeutic potential of these antibodies as indirect immunizers in combination with other immune modulating drugs or drug combinations to address unmet medical needs in oncology.
Quest PharmaTech, Inc. is a biotechnology company, which develops and commercializes antibody based immunotherapeutic products for cancer. The company is headquartered in Edmonton, Alberta. The firm is focused on development and commercialization of immunotherapies for cancer. Its technology platform includes a portfolio of tumor antigen specific monoclonal immunoglobulins targeting CA-125, MUC1, PSA and Her2/neu. The firm is also developing products utilizing transdermal delivery technologies with a focus on dermatology and wound healing applications. The firm is exploring the therapeutic potential of these antibodies as indirect immunizers in combination with other immune modulating drugs or drug combinations to address unmet medical needs in oncology.